Abstract:Highlights • mGluR5 PAM pre-treatment prevents MK-801 induced increased extracellular glutamate. • mGluR5 PAM does not affect mPFC extracellular glutamate when given alone. • mGluR5 PAM may restore cognitive function by regulating mPFC glutamate. • Targeting mGluR5 with PAMs may treat neuropsychiatric disorder impairments. Potentiation of metabotropic glutamate receptor subtype 5 (mGluR5) function produces antipsychotic-like and pro-cognitive effects in animal models of schizophrenia and can reverse cognitive deficits induced by N-methyl-D-aspartate type glutamate receptor (NMDAR) antagonists. However, it is currently unknown if mGluR5 positive allosteric modulators (PAMs) can modulate NMDAR antagonist-induced alterations in extracellular glutamate levels in regions underlying these cognitive and behavioral effects, such as the medial prefrontal cortex. We therefore assessed the ability of the mGluR5 PAM, 3-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl) benzamide (CDPPB), to reduce elevated extracellular glutamate levels induced by the NMDAR antagonist, dizocilpine (MK-801), in the medial prefrontal cortex. Male Sprague-Dawley rats were implanted with a guide cannula aimed at the medial prefrontal cortex and treated for ten consecutive days with MK-801 and CDPPB or their corresponding vehicles. CDPPB or vehicle was administered thirty minutes before MK-801 or vehicle each day. On the final day of treatment, in vivo microdialysis was performed, and samples were collected every thirty minutes to analyze extracellular glutamate levels. Compared to animals receiving only vehicle, administration of MK-801 alone significantly increased extracellular levels of glutamate in the mPFC. This effect was not observed in animals administered CDPPB before MK-801, nor in those administered CDPPB alone, indicating that CDPPB decreased extracellular glutamate release stimulated by MK-801. Results indicate that CDPPB attenuates MK-801 induced elevations in extracellular glutamate in the medial prefrontal cortex. This effect of CDPPB may underlie neurochemical adaptations associated with the pro-cognitive effects of mGluR5 PAMs in rodent models of schizophrenia. Graphical abstract Download: Download high-res image (95KB) Download: Download full-size image

Paliperidone Alleviates MK-801-induced Damage to Prefrontal Cortical Neurons Via the PP2A/PTEN Pathway.

Paliperidone Protects Prefrontal Cortical Neurons from Damages Caused by MK-801 Via Akt1/GSK3β Signaling Pathway

Paliperidone Protects SH-SY5Y Cells Against MK-801-Induced Neuronal Damage Through Inhibition of Ca 2+ Influx and Regulation of SIRT1/miR-134 Signal Pathway

Paliperidone Protects SK-N-SH Cells Against Glutamate Toxicity Via Akt1/GSK3β Signaling Pathway.

Psychotomimetic Effects of Different Doses of MK-801 and the Underlying Mechanisms in a Selective Memory Impairment Model

Neuroprotection of paliperidone on SH-SY5Y cells against β-amyloid peptide25-35, N-methyl-4-phenylpyridinium ion, and hydrogen peroxide-induced cell death

Effects of paliperidone on MK-801-induced hyperactivity and disruption prepulse inhibition in rats

Depletion of Microglia with PLX3397 Attenuates MK-801-induced Hyperactivity Associated with Regulating Inflammation-Related Genes in the Brain

The effects of repeated administrations of MK-801 on ERK and GSK-3beta signalling pathways in the rat frontal cortex

Paliperidone Increases Spontaneous and Evoked Firing of Mesocortical Dopaminergic Neurons by Activating a Hyperpolarization-Activated Inward Current

Studies on the Acute Toxicity, Pharmacokinetics and Pharmacodynamics of Paliperidone Derivatives - Comparison to Paliperidone and Risperidone in Mice and Rats

Improvement of Mitochondrial Function by Paliperidone Attenuates Quinolinic Acid-Induced Behavioural and Neurochemical Alterations in Rats: Implications in Huntington’s Disease

mGluR5 Positive Allosteric Modulation Prevents MK-801 Induced Increases in Extracellular Glutamate in the Rat Medial Prefrontal Cortex

Paeoniflorin Rescued MK-801-Induced Schizophrenia-Like Behaviors in Mice via Oxidative Stress Pathway

Neuroprotective Effects of Protocatechuic Aldehyde Against Neurotoxin-Induced Cellular and Animal Models of Parkinson’s Disease

Activation of A2B Adenosine Receptor Protects Against Demyelination in a Mouse Model of Schizophrenia

Chemogenetic attenuation of PFC pyramidal neurons restores deficits in recognition memory following adolescent NMDA receptor blockade

Enhanced interaction among ErbB4, PSD-95 and NMDAR by chronic MK-801 treatment is associated with behavioral abnormalities.

Palmatine Ameliorates Motor Deficits and Dopaminergic Neuron Loss by Regulating NLRP3 Inflammasome through Mitophagy in Parkinson's Disease Model Mice

Oleanolic acid attenuates MK-801-induced schizophrenia-like behaviors in mice

Activation of basolateral amygdala to anterior cingulate cortex circuit alleviates MK-801 induced social and cognitive deficits of schizophrenia